Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
Phase 1/2 Recruiting
38 enrolled
Pembrolizumab + Poly-ICLC in MRP Colon Cancer
Phase 1/2 Completed
42 enrolled 13 charts
Vaccination With Flt3L, Radiation, and Poly-ICLC
Phase 1/2 Unknown
56 enrolled
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Phase 1/2 Completed
40 enrolled 15 charts
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Phase 1/2 Completed
58 enrolled 24 charts
Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs
Phase 1/2 Terminated
1 enrolled 6 charts
Safety Study of Adjuvant Vaccine to Treat Melanoma Patients
Phase 1/2 Completed
34 enrolled 10 charts
Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma
Phase 1/2 Completed
19 enrolled
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Phase 1/2 Unknown
50 enrolled